{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:34:18Z","timestamp":1791470058264,"version":"4.3.4"},"reference-count":38,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"681","content-domain":{"domain":["www.science.org"],"crossmark-restriction":true},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:p>Immunogenicity against intravitreally administered brolucizumab has been previously described and associated with cases of severe intraocular inflammation, including retinal vasculitis\/retinal vascular occlusion (RV\/RO). The presence of antidrug antibodies (ADAs) in these patients led to the initial hypothesis that immune complexes could be key mediators. Although the formation of ADAs and immune complexes may be a prerequisite, other factors likely contribute to some patients having RV\/RO, whereas the vast majority do not. To identify and characterize the mechanistic drivers underlying the immunogenicity of brolucizumab and the consequence of subsequent ADA-induced immune complex formation, a translational approach was performed to bridge physicochemical characterization, structural modeling, sequence analysis, immunological assays, and a quantitative systems pharmacology model that mimics physiological conditions within the eye. This approach revealed that multiple factors contributed to the increased immunogenic potential of brolucizumab, including a linear epitope shared with bacteria, non-natural surfaces due to the single-chain variable fragment format, and non-native drug species that may form over prolonged time in the eye. Consideration of intraocular drug pharmacology and disease state in a quantitative systems pharmacology model suggested that immune complexes could form at immunologically relevant concentrations modulated by dose intensity. Assays using circulating immune cells from treated patients or treatment-na\u00efve healthy volunteers revealed the capacity of immune complexes to trigger cellular responses such as enhanced antigen presentation, platelet aggregation, endothelial cell activation, and cytokine release. Together, these studies informed a mechanistic understanding of the clinically observed immunogenicity of brolucizumab and associated cases of RV\/RO.<\/jats:p>","DOI":"10.1126\/scitranslmed.abq5068","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T18:58:18Z","timestamp":1675277898000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark","source":"Crossref","is-referenced-by-count":41,"title":["A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab"],"prefix":"10.1126","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7261-5096","authenticated-orcid":true,"given":"Jeffrey D.","family":"Kearns","sequence":"first","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7391-1065","authenticated-orcid":true,"given":"Paul","family":"Wassmann","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Olgac","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3869-3669","authenticated-orcid":true,"given":"Marie","family":"Fichter","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3157-3816","authenticated-orcid":true,"given":"Brigitte","family":"Christen","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6704-3783","authenticated-orcid":true,"given":"Tina","family":"Rubic-Schneider","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4739-6394","authenticated-orcid":true,"given":"Stephan","family":"Koepke","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Cochin de Billy","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5980-7306","authenticated-orcid":true,"given":"David","family":"Ledieu","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5827-0105","authenticated-orcid":true,"given":"Cedric","family":"Andre","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5754-061X","authenticated-orcid":true,"given":"Stuart","family":"Hawtin","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9911-1397","authenticated-orcid":true,"given":"Benoit","family":"Fischer","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0920-1063","authenticated-orcid":true,"given":"Francesca","family":"Moretti","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7641-6972","authenticated-orcid":true,"given":"Christian","family":"Hug","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bepperling","sequence":"additional","affiliation":[{"name":"TRD Biologics and CGT, Novartis Pharma AG, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9436-0362","authenticated-orcid":true,"given":"Barbara","family":"Brannetti","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5384-1597","authenticated-orcid":true,"given":"Celia","family":"Mendez-Garcia","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7760-6535","authenticated-orcid":true,"given":"Amanda","family":"Littlewood-Evans","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6192-1557","authenticated-orcid":true,"given":"Andreas","family":"Clemens","sequence":"additional","affiliation":[{"name":"Medical Affairs Region Europe, Novartis Pharma AG, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia L.","family":"Grosskreutz","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3539-3556","authenticated-orcid":true,"given":"Pawan","family":"Mehan","sequence":"additional","affiliation":[{"name":"TRD Biologics and CGT, Novartis Pharma AG, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9896-7305","authenticated-orcid":true,"given":"Robert L.","family":"Schmouder","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, East Hanover, NJ 07960, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2852-7931","authenticated-orcid":true,"given":"Vito","family":"Sasseville","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-0753","authenticated-orcid":true,"given":"Dominique","family":"Brees","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0567-9708","authenticated-orcid":true,"given":"Anette C.","family":"Karle","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel CH-4056, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.12.031"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.11.011"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00021"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2020.1772053"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/2042098611406318"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5358272"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.330902"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086322"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016001842"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601629"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.5414\/CN107304"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.500"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2010.0086"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1048411"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-013-9492-4"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2019.1612699"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-016-9878-1"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.2.3.11780"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9915-0"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq5241"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.29883"},{"key":"e_1_3_3_23_2","first-page":"695","article-title":"Ocular half-life of intravitreal biologics in humans and other species: Meta-analysis and model-based prediction","volume":"17","author":"Caruso A.","year":"2020","unstructured":"A.\u00a0Caruso, M.\u00a0Futh, R.\u00a0Alvarez-S\u00e1nchez, S.\u00a0Belli, C.\u00a0Diack, K. F.\u00a0Maass, D.\u00a0Schwab, H.\u00a0Kettenberger, N. A.\u00a0Mazer, Ocular half-life of intravitreal biologics in humans and other species: Meta-analysis and model-based prediction. Mol. Pharm. 17, 695\u2013709 (2020).","journal-title":"Mol. Pharm."},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00280"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16330"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-019-2689-1"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061254"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2010.3522"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.5551\/jat.11.15"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.011192"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/0192623310378866"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.017"},{"key":"e_1_3_3_33_2","unstructured":"R. Schmouder B.\u00a0Maciejewski A.\u00a0Karle J.\u00a0Glick T.\u00a0Rubic-Schneider D.\u00a0Ledieu J.\u00a0Watts D.\u00a0Brees paper presented at the Annual Meeting of EURETINA 2021 Meeting 9\u201312 September 2021."},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)76693-0"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0603-3"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giy100"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/mlf2.12017"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1136761"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00698"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.abq5068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T17:06:14Z","timestamp":1705424774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.abq5068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":38,"journal-issue":{"issue":"681","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1126\/scitranslmed.abq5068"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.abq5068","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"2022-04-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"eabq5068"}}